Patients	O	0,8
were	O	9,13
classified	O	14,24
as	O	25,27
having	O	28,34
LM	B-KP	35,37
if	O	38,40
they	O	41,45
met	O	46,49
the	O	50,53
criteria	O	54,62
established	O	63,74
by	O	75,77
the	O	78,81
CDC	O	82,85
for	O	86,89
Lyme	B-KP	90,94
disease	I-KP	95,102
(	O	103,104
positive	O	104,112
serology	O	113,121
with	O	122,126
Western	O	127,134
blot	O	135,139
confirmation	O	140,152
or	O	153,155
erythema	B-KP	156,164
migrans	I-KP	165,172
observed	O	173,181
by	O	182,184
a	O	185,186
physician	O	187,196
)	O	196,197
and	O	198,201
had	O	202,205
meningitis	O	206,216
.	O	216,217
[	O	218,219
1	O	219,220
]	O	220,221
Criteria	O	222,230
for	O	231,234
serologic	B-KP	235,244
diagnosis	I-KP	245,254
were	O	255,259
based	O	260,265
on	O	266,268
published	O	269,278
criteria	O	279,287
for	O	288,291
results	O	292,299
from	O	300,304
commercial	O	305,315
laboratories	O	316,328
[	O	329,330
8	O	330,331
]	O	331,332
and	O	333,336
our	O	337,340
hospital's	O	341,351
laboratory	O	352,362
.	O	362,363
[	O	364,365
9	O	365,366
]	O	366,367
If	O	368,370
initial	O	371,378
Lyme-serology	B-KP	379,392
results	I-KP	393,400
were	O	401,405
equivocal	O	406,415
but	O	416,419
follow-up	O	420,429
testing	O	430,437
was	O	438,441
positive	O	442,450
,	O	450,451
these	O	452,457
children	O	458,466
were	O	467,471
considered	O	472,482
to	O	483,485
have	O	486,490
Lyme	B-KP	491,495
disease	I-KP	496,503
.	O	503,504

Patients	O	505,513
with	O	514,518
meningitis	O	519,529
who	O	530,533
did	O	534,537
not	O	538,541
meet	O	542,546
CDC	O	547,550
criteria	O	551,559
for	O	560,563
Lyme	B-KP	564,568
disease	I-KP	569,576
were	O	577,581
classified	O	582,592
as	O	593,595
having	O	596,602
AM	B-KP	603,605
.	O	605,606
The	O	607,610
final	O	611,616
discharge	O	617,626
diagnosis	O	627,636
of	O	637,639
all	O	640,643
patients	O	644,652
was	O	653,656
extracted	O	657,666
from	O	667,671
the	O	672,675
medical	O	676,683
chart	O	684,689
.	O	689,690

Laboratory	O	691,701
values	O	702,708
(	O	709,710
Lyme	B-KP	710,714
serology	I-KP	715,723
,	O	723,724
CSF	B-KP	725,728
red	I-KP	729,732
blood	I-KP	733,738
cell	I-KP	739,743
count	I-KP	744,749
,	O	749,750
CSF	B-KP	751,754
WBC	I-KP	755,758
,	O	758,759
CSF	B-KP	760,763
WBC	I-KP	764,767
differential	I-KP	768,780
,	O	780,781
CSF	B-KP	782,785
bacterial	I-KP	786,795
culture	I-KP	796,803
,	O	803,804
CSF	B-KP	805,808
viral	I-KP	809,814
culture	I-KP	815,822
,	O	822,823
and	O	824,827
CSF	B-KP	828,831
enterovirus	I-KP	832,843
PCR	I-KP	844,847
)	O	847,848
and	O	849,852
demographic	O	853,864
information	O	865,876
(	O	877,878
age	O	878,881
,	O	881,882
gender	O	883,889
,	O	889,890
race	O	891,895
,	O	895,896
and	O	897,900
month	O	901,906
of	O	907,909
presentation	O	910,922
)	O	922,923
were	O	924,928
abstracted	O	929,939
electronically	O	940,954
from	O	955,959
our	O	960,963
hospital’s	O	964,974
laboratory	O	975,985
database	O	986,994
.	O	994,995

Lyme	B-KP	996,1000
serology	I-KP	1001,1009
was	O	1010,1013
completed	O	1014,1023
by	O	1024,1026
our	O	1027,1030
hospital	O	1031,1039
laboratory	O	1040,1050
using	O	1051,1056
a	O	1057,1058
previously	O	1059,1069
described	O	1070,1079
protocol	O	1080,1088
.	O	1088,1089
[	O	1090,1091
9	O	1091,1092
]	O	1092,1093
Standard	O	1094,1102
techniques	O	1103,1113
were	O	1114,1118
used	O	1119,1123
for	O	1124,1127
CSF	B-KP	1128,1131
bacterial	I-KP	1132,1141
and	I-KP	1142,1145
viral	I-KP	1146,1151
cultures	I-KP	1152,1160
.	O	1160,1161

The	O	1162,1165
virology	O	1166,1174
laboratory	O	1175,1185
of	O	1186,1188
the	O	1189,1192
Children's	O	1193,1203
Hospital	O	1204,1212
of	O	1213,1215
Philadelphia	O	1216,1228
(	O	1229,1230
Philadelphia	O	1230,1242
,	O	1242,1243
PA	O	1244,1246
)	O	1246,1247
performed	O	1248,1257
all	O	1258,1261
enterovirus	B-KP	1262,1273
CSF	I-KP	1274,1277
PCR	I-KP	1278,1281
testing	I-KP	1282,1289
.	O	1289,1290

